These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28803922)

  • 1. Studying furosemide solubilization using an in vitro model simulating gastrointestinal digestion and drug solubilization in neonates and young infants.
    Klitgaard M; Sassene PJ; Selen A; Müllertz A; Berthelsen R
    Eur J Pharm Sci; 2017 Nov; 109():191-199. PubMed ID: 28803922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
    Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
    AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats.
    Christfort JF; Strindberg S; Plum J; Hall-Andersen J; Janfelt C; Nielsen LH; Müllertz A
    Eur J Pharm Biopharm; 2019 Sep; 142():307-314. PubMed ID: 31288077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug solubilization during simulated pediatric gastro-intestinal digestion.
    Kofoed-Djursner C; Jamil A; Selen A; Müllertz A; Berthelsen R
    Eur J Pharm Sci; 2021 Jul; 162():105828. PubMed ID: 33819625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
    Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations.
    Ozdemir N; Ordu S; Ozkan Y
    Drug Dev Ind Pharm; 2000 Aug; 26(8):857-66. PubMed ID: 10900542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate.
    Sallam AS; Khalil E; Ibrahim H; Freij I
    Eur J Pharm Biopharm; 2002 May; 53(3):343-52. PubMed ID: 11976023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification.
    Cvijić S; Parojčić J; Langguth P
    Eur J Pharm Sci; 2014 Sep; 61():40-53. PubMed ID: 24751672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate.
    Schultz HB; Joyce P; Thomas N; Prestidge CA
    Pharm Res; 2020 Mar; 37(4):77. PubMed ID: 32236761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of food effect on the oral absorption of clarithromycin from immediate release tablet using physiological modelling.
    Radwan A; Jayyousi R; Shraim N; Zaid AN
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):121-134. PubMed ID: 30891805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model.
    Derakhshandeh K; Hosseinalizadeh A; Nikmohammadi M
    Arch Pharm Res; 2011 Nov; 34(11):1989-97. PubMed ID: 22139699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of a Single Experimental Design for the Optimization of Furosemide Modified-Release Tablet Formulations.
    Vlachou M; Siamidi A; Dotsikas Y
    Curr Drug Deliv; 2019; 16(10):931-939. PubMed ID: 31663479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Simulated Stomach Duodenum Model Predicting the Effect of Fluid Volume and Prandial Gastric Flow Patterns on Nifedipine Pharmacokinetics From Cosolvent-Based Capsules.
    Honigford CR; Aburub A; Fadda HM
    J Pharm Sci; 2019 Jan; 108(1):288-294. PubMed ID: 30075162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes.
    Yang W; de Villiers MM
    J Pharm Pharmacol; 2004 Jun; 56(6):703-8. PubMed ID: 15231034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.
    Koziolek M; Carrière F; Porter CJH
    Pharm Res; 2018 Feb; 35(3):55. PubMed ID: 29423732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form.
    Souliman S; Blanquet S; Beyssac E; Cardot JM
    Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.